ClinicalTrials.Veeva

Menu

Neonatal Neurologic Intensive Care Network of China

Fudan University logo

Fudan University

Status

Enrolling

Conditions

Neonatal Encephalopathy
Suspected Neonatal Encephalopathy

Treatments

Other: Database Entry/Biospecimen Collection

Study type

Observational

Funder types

Other

Identifiers

NCT02544100
CHFudanU_NNICU5

Details and patient eligibility

About

The purpose of this study is to create a neonatal neurologic biological big data center named Neonatal Neurologic Intensive Care Network in China with neonatal systematic information, biological samples and genomics & genetic data on neonates born with neonatal severe encephalopathy. It also can predict brain injury as cerebral function monitoring through big data and recommend appropriate treatment. In addition, the following samples will be collected in a bio-bank in for future studies: blood, urine, and cerebrospinal fluid (CSF) samples.

Full description

The purpose of this study is to create a neonatal neurologic biological big data center named Neonatal Neurologic Intensive Care Network in China with neonatal systematic information mainly including demographic, medical history, family condition, perinatal stage information, birth, growth & feeding status, imaging, biological samples and genomics & genetic data on neonates born with neonatal severe encephalopathy. It also can predict brain injury as cerebral function monitoring through big data and recommend appropriate treatment. There are seven children's hospitals from 6 provinces in China to join in the collaboration network in first recruiting. In addition, the following biological samples will be collected in a bio-bank for future studies: blood, urine, and cerebrospinal fluid (CSF) samples.

Enrollment

2,000 estimated patients

Sex

All

Ages

Under 28 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Postnatal age < or = 28 days

  2. Written informed consent of parent or guardian

    With one of the following items

  3. Hypoxic ischemic encephalopathy (HIE)

  4. Hydrocephalus

  5. Hypotonia

  6. Interventricular hemorrhages

  7. Intracranial calcifications

  8. Intracranial hemorrhages

  9. Meningitis and other brain infections

  10. Metabolic diseases

  11. Microcephaly

  12. Neonatal stroke

  13. Spina bifid

  14. Cerebral arteriovenous malformations (AVMs)

  15. Congenital brain malformations

Exclusion criteria

  1. Known other major congenital anomalies but not not neurologic disease.
  2. Failed to get sample or the volume of collected biosamples is not enough.
  3. Parents refuse consent.

Trial design

2,000 participants in 1 patient group

Database Entry / Biospecimen Collection
Description:
Systematic Medical information of infants born with severe encephalopathy entered into database. In addition, Blood, urine, CFS samples will be collected.
Treatment:
Other: Database Entry/Biospecimen Collection

Trial contacts and locations

1

Loading...

Central trial contact

Guoqiang Cheng, Doctor; Wenhao Zhou, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems